Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor
In Reply.—There has been a wide polemic concerning the ingredients contained in the SKIN-CAP product and, at this time, Cheminova International, SA, does not want to enter into more discussion.
The final evidence for the defense of SKIN-CAP has been provided to the corresponding FDA inspectors, and it is now their turn to make a decision and to inform us and the public about their verdict.
After several analyses conducted by official institutions, SKIN-CAP has been reintroduced in the United Kingdom, Germany, France, and most East European countries. We trust that the US FDA will follow the decision of their European colleagues and will allow a prompt return of SKIN-CAP to the US market.
Santa Marta AF. Women's Health Research. JAMA. 1998;280(4):327-328. doi:10-1001/pubs.JAMA-ISSN-0098-7484-280-4-jbk0722